An Investigational New Drug (IND) is a drug or biological drug that has not been approved for general use by the FDA. It is used in a clinical trial to investigate its safety and efficacy. The term ...
Gilead Sciences, Inc. (Nasdaq: GILD) today announced that the U.S. Food and Drug Administration (FDA) has accepted its New ...
The road map will specify the timeline for filing investigational new drug applications for each drug in the pipeline. Updates will focus on two ADC-based cancer drugs, CT-P70 and CT-P71 ...
U.S.-based PleoPharma announced yesterday that the FDA has granted it a fast-track designation for PP-01, a new ...
The last decade has seen a “dramatic increase” in investigational new drug (IND) applications for cannabis-derived products, according to the U.S. Food and Drug Administration. In a paper ...
The patent expands the covered methods of identifying patients with specific genetic markers linked to substance use disorders and treating them with AD04, the company's investigational new drug ...
The University of Chicago will receive up to $130 million in funding over the next 10 years as part of a new drug research ...
Principal Investigators on treatment protocols that involve an Investigational New Drug (IND) must complete Form FDA 1572, which the sponsor then submits to FDA. Form FDA 1572 is the contract between ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback